Literature DB >> 20490932

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.

Ambros J Beer1, Matthias Eiber, Michael Souvatzoglou, Konstantin Holzapfel, Carl Ganter, Gregor Weirich, Tobias Maurer, Hubert Kübler, Hans-Juergen Wester, Jochen Gaa, Bernd J Krause.   

Abstract

PURPOSE: (11)C-Choline-positron emission tomography (PET)/computed tomography (CT) is increasingly used in patients with prostate cancer. Another promising technique for assessment of tumor biology is diffusion-weighted MR imaging (DWI). The aim of the study was to compare the functional parameters standardized uptake value (SUV) in PET and apparent diffusion coefficient (ADC) value in DWI of lymph nodes in prostate cancer patients. PROCEDURES: Fourteen patients with prostate cancer underwent DWI at 1.5T and (11)C-Choline-PET/CT. ADC values and SUVs of all lymph nodes larger than 5 mm (n = 55) were compared by using linear regression analysis. Performance of DWI and (11)C-Choline PET was assessed by receiver operator characteristic curve analysis using histopathology or clinical follow-up as standard of reference.
RESULTS: ADC values and SUV showed a moderate but highly significant inverse correlation (r = -0.5144, p < 0.0001). In lymph nodes with low ADC values, the dispersion of SUV was more pronounced. Moreover, a highly significant difference was observed for mean ADC values and SUV in lymph nodes considered as benign or malignant by follow-up/histopathology (ADC 1.60 ± 0.24 vs. 1.09 ± 0.23 × 10(-3) mm(2)/s; SUV 1.82 ± 0.57 vs. 4.68 ± 03.12; p < 0.0001, respectively).
CONCLUSION: These pilot data propose the ADC value in DWI as a new potential imaging biomarker which might provide additional information on tumor pathophysiology compared to the SUV in (11)C-Choline PET/CT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20490932     DOI: 10.1007/s11307-010-0337-6

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  58 in total

1.  Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method.

Authors:  R Katz-Brull; H Degani
Journal:  Anticancer Res       Date:  1996 May-Jun       Impact factor: 2.480

2.  11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.

Authors:  Soichiro Yoshida; Kazuaki Nakagomi; Shuichi Goto; Masami Futatsubashi; Tatsuo Torizuka
Journal:  Urol Int       Date:  2005       Impact factor: 2.089

3.  Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.

Authors:  C Hofer; C Laubenbacher; T Block; J Breul; R Hartung; M Schwaiger
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

4.  Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging.

Authors:  J Wang; S Takashima; F Takayama; S Kawakami; A Saito; T Matsushita; M Momose; T Ishiyama
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

5.  Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI.

Authors:  Russell N Low; Jonathan Gurney
Journal:  J Magn Reson Imaging       Date:  2007-04       Impact factor: 4.813

6.  Choline transporter as a novel target for molecular imaging of cancer.

Authors:  Toshihiko Hara; Aditya Bansal; Timothy R DeGrado
Journal:  Mol Imaging       Date:  2006 Oct-Dec       Impact factor: 4.488

7.  Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.

Authors:  Tatsuo Torizuka; Toshihiko Kanno; Masami Futatsubashi; Hiroyuki Okada; Etsuji Yoshikawa; Fumitoshi Nakamura; Munetaka Takekuma; Makoto Maeda; Yasuomi Ouchi
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

8.  Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.

Authors:  Ludwig Rinnab; Felix M Mottaghy; Norbert M Blumstein; Sven N Reske; Richard E Hautmann; Kathrin Hohl; Peter Möller; Thomas Wiegel; Rainer Kuefer; Juergen E Gschwend
Journal:  BJU Int       Date:  2007-10       Impact factor: 5.588

9.  Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.

Authors:  Liang Wang; Hedvig Hricak; Michael W Kattan; Lawrence H Schwartz; Steven C Eberhardt; Hui-Ni Chen; Peter T Scardino
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

Review 10.  The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy.

Authors:  J S Wolf; M Cher; M Dall'era; J C Presti; H Hricak; P R Carroll
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

View more
  26 in total

Review 1.  Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer's perspective.

Authors:  Antonis Kalemis; Bénédicte M A Delattre; Susanne Heinzer
Journal:  MAGMA       Date:  2012-08-07       Impact factor: 2.310

Review 2.  Molecular imaging of prostate cancer: PET radiotracers.

Authors:  Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

3.  ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer.

Authors:  Gilda Rechichi; Stefania Galimberti; Matteo Oriani; Patrizia Perego; Maria Grazia Valsecchi; Sandro Sironi
Journal:  Eur Radiol       Date:  2012-07-21       Impact factor: 5.315

4.  Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.

Authors:  Matthias Eiber; Axel Martinez-Möller; Michael Souvatzoglou; Konstantin Holzapfel; Anja Pickhard; Dennys Löffelbein; Ivan Santi; Ernst J Rummeny; Sibylle Ziegler; Markus Schwaiger; Stephan G Nekolla; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-18       Impact factor: 9.236

5.  Introducing parametric fusion PET/MRI of primary prostate cancer.

Authors:  Hyunjin Park; David Wood; Hero Hussain; Charles R Meyer; Rajal B Shah; Timothy D Johnson; Thomas Chenevert; Morand Piert
Journal:  J Nucl Med       Date:  2012-03-14       Impact factor: 10.057

6.  Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.

Authors:  Sang Hee Park; Woo Kyung Moon; Nariya Cho; Jung Min Chang; Seock-Ah Im; In Ae Park; Keon Wook Kang; Wonshik Han; Dong-Young Noh
Journal:  Eur Radiol       Date:  2011-08-16       Impact factor: 5.315

7.  Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.

Authors:  Matthias M Heck; Michael Souvatzoglou; Margitta Retz; Roman Nawroth; Hubert Kübler; Tobias Maurer; Mark Thalgott; Bettina M Gramer; Gregor Weirich; Ina-Christine Rondak; Ernst J Rummeny; Markus Schwaiger; Jürgen E Gschwend; Bernd Krause; Matthias Eiber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-03       Impact factor: 9.236

8.  Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer.

Authors:  Andrew D Hardie; William J Rieter; Marques L Bradshaw; Leonie L Gordon; Matthew A Young; Thomas E Keane
Journal:  World J Urol       Date:  2013-04-18       Impact factor: 4.226

Review 9.  Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.

Authors:  Paola Mapelli; Maria Picchio
Journal:  Nat Rev Urol       Date:  2015-08-11       Impact factor: 14.432

10.  Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.

Authors:  Tibor Vag; Matthias M Heck; Ambros J Beer; Michael Souvatzoglou; Gregor Weirich; Konstantin Holzapfel; Ernst J Rummeny; Markus Schwaiger; Bernd Joachim Krause; Matthias Eiber
Journal:  Eur Radiol       Date:  2014-06-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.